Back

Implementation and first results of the Czech nationwide prostate cancer screening pilot programme

2026-01-13 oncology Title + abstract only
View on medRxiv
Show abstract

BackgroundIn 2022, the European Union recommended piloting organised prostate cancer screening. Subsequently, the Czech Republic launched a nationwide pilot programme fully reimbursed by public health insurance in January 2024 to reduce the high incidence of late-stage prostate cancer and the widespread unorganised prostate-specific antigen (PSA) testing. ObjectiveTo describe the strategy, methodology, and first results of the Czech nationwide prostate cancer screening pilot programme. Methods...

Predicted journal destinations